NITI Aayog (health) member VK Paul said that not only Bharat Biotech’s Covaxin, but Zydus Cadila’s vaccine is already being tested on children. Zydus Cadila is testing its Covid-19 vaccine candidate on children in the age group of 12-18 years, apart from adults, and the Ahmedabad-based company is likely to apply for licensure of the vaccine in the next two weeks. It was said, ZyCoV-D was found to be safe, well-tolerated, and immunogenic in the Adaptive Phase I/II clinical trials,” Zydus Cadila has said.